![Joseph Wagner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Wagner
Keine laufenden Positionen mehr
Profil
Joseph P.
Wagner served as Chief Executive Officer at Insight Molecular Diagnostics, Inc. Served as President, Chief Executive Officer & Director at BriaCell Therapeutics Corp.
from 2015 to 2016.
Served as Executive Director at University of California Drug Discovery Consortium.
Served as Vice President-Cellular Therapy at Neuronyx, Inc. Served as President at Cell Targeting, Inc. Served as Chief Scientific Officer at Notable Labs Ltd. from 2020 to 2024.
Education includes undergraduate studies at Rochester Christian University and a doctorate from Duke University School of Medicine.
Ehemalige bekannte Positionen von Joseph Wagner
| Unternehmen | Position | Ende |
|---|---|---|
| BRIACELL THERAPEUTICS CORP. | Vorstandsvorsitzender | 24.03.2016 |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells | Corporate Officer/Principal | 13.10.2009 |
University of California Drug Discovery Consortium | Direktor/Vorstandsmitglied | - |
Cell Targeting, Inc.
 Cell Targeting, Inc. BiotechnologyHealth Technology Provides research and development of aqueous-based synthetic solutions | Präsident | - |
Ausbildung von Joseph Wagner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells | Health Technology |
Cell Targeting, Inc.
Cell Targeting, Inc. BiotechnologyHealth Technology Provides research and development of aqueous-based synthetic solutions | Health Technology |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BriaCell Therapeutics Corp.
 BriaCell Therapeutics Corp. BiotechnologyHealth Technology Operates as an immuno-oncology biotechnology company which develops targeted approaches for the management of breast cancer | Health Technology |
University of California Drug Discovery Consortium |
